Innate Pharma S.A. (IPHA)
NASDAQ: IPHA
· Real-Time Price · USD
1.87
-0.04 (-2.09%)
At close: Jun 27, 2025, 2:35 PM
Innate Pharma S.A. Revenue
Innate Pharma S.A. reported an annual revenue of $12.62M, reflecting a -75.68% growth. For the quarter ending December 31, 2024, Innate Pharma S.A. generated $276K in revenue.
Revenue (ttm)
$12.62M
Revenue Growth
-75.68%
Price / Sales Ratio
11.41
Revenue / Employee
$69.73K
Employees
181
Market Cap
172.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|